Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for UCB-Pharma
Company Monitoring Page for UCB-Pharma
latest headlines for company on cafepharma
UCB launches DTC Bimzelx ad blitz at the Oscars
Medical Marketing and Media
Sun, 03/10/24 - 08:23 pm
Tags:
UCB Pharma
,
DTC advertising
,
Oscars
,
psoriasis
Seeking blockbuster status, UCB eyes 4 new indications for psoriasis med Bimzelx in 2024
Fierce Pharma
Wed, 02/28/24 - 09:47 pm
Tags:
UCB Pharma
,
Bimzelx
After Pfizer's exit, UCB splits from industry trade group BIO
Fierce Pharma
Sun, 01/7/24 - 04:20 pm
Tags:
UCB Pharma
,
BIO
,
Pfizer
Lilly, UCB-Backed ViaNautis Scores $25M for Genetic Nanomedicines
BioSpace
Mon, 11/13/23 - 11:58 am
Tags:
ViaNautis Bio
,
Eli Lilly
,
genetic nanomedicine
,
UCB Pharma
,
funding
FDA Approves UCB’s Complement Inhibitor for Generalized Myasthenia Gravis
BioSpace
Wed, 10/18/23 - 11:22 am
Tags:
UCB Pharma
,
Zilbrysq
,
myasthenia gravis
UCB stakes claim to gMG market as FDA clears Rystiggo
Pharmaphorum
Tue, 06/27/23 - 11:21 am
Tags:
UCB Pharma
,
Rystiggo
,
myasthenia gravis
,
FDA
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
Tags:
FDA
,
Albireo Pharma
,
Aldeyra Therapeutics
,
Alvotech
,
Amneal Pharmaceuticals
,
Argenx
,
ARS Pharmaceuticals
,
AstraZeneca
,
Bayer
,
Bio-Thera Solutions
,
Biogen
,
BioMarin Pharmaceutical
,
Bristol Myers Squibb
,
Eisai
,
Eton Pharmaceuticals
,
F2G
,
Fabre-Kramer Pharmaceuticals
,
Fresenius
,
GSK
,
Intercept Pharmaceuticals
,
Ipsen
,
Ironwood Pharmaceuticals
,
Merck
,
Novaliq
,
Pfizer
,
Regeneron
,
Roche
,
Sanofi
,
Sarepta Therapeutics
,
Shionogi
,
Swedish Orphan Biovitrum
,
Takeda
,
Teva Pharmaceutica
,
UCB Pharma
UCB partners with Ariceum for treatment of immune-related diseases and cancer
Biopharma Reporter
Fri, 05/12/23 - 11:30 am
Tags:
UCB Pharma
,
Ariceum
,
R&D
,
radiopharmaceuticals
,
solid tumors
In upcoming skin disease clash, doctors see Novartis' Cosentyx as an underdog
Fierce Pharma
Tue, 04/11/23 - 10:04 am
Tags:
Novartis
,
Cosentyx
,
AbbVie
,
Humira
,
hidradenitis suppurativa
,
UCB Pharma
Spotlight – following Humira in hidradenitis suppurativa
EP Vantage
Tue, 04/4/23 - 10:10 am
Tags:
AbbVie
,
Humira
,
hidradenitis suppurativa
,
UCB Pharma
,
Bimzelx
,
MoonLake Immunotherapeutics
AAD 2023 – UCB and Acelyrin take aim at hidradenitis suppurativa
EP Vantage
Tue, 03/21/23 - 09:54 am
Tags:
AAD
,
hidradenitis suppurativa
,
AbbVie
,
Humira
,
UCB Pharma
,
Bimzelx
,
Acelyrin
,
izokibep
UCB's bimekizumab finally back on the FDA's review list after May rejection
Fierce Pharma
Wed, 12/28/22 - 08:40 pm
Tags:
UCB Pharma
,
psoriasis
,
bimekizumab
,
FDA
Praxis ends year on high with $100M biobucks UCB deal for epilepsy medicine
Fierce Biotech
Wed, 12/14/22 - 07:40 pm
Tags:
Praxis
,
UCB Pharma
,
epilepsy
,
PRAX-020
UCB lowers 2022 profit expectations amid Ukraine war, rising costs
Fierce Pharma
Mon, 06/27/22 - 10:09 am
Tags:
UCB Pharma
,
Ukraine
,
Russia
,
generics
UCB’s FDA setback delays competition in U.S. with blockbuster J&J psoriasis drug
MedCity News
Sun, 05/15/22 - 11:12 pm
Tags:
UCB Pharma
,
bimekizumab
,
psoriasis
,
FDA
,
JNJ
UCB takes on Jazz in severe epilepsy with new Fintepla approval
Pharmaforum
Mon, 03/28/22 - 10:06 am
Tags:
UCB Pharma
,
FDA
,
Fintepla
,
Lennox-Gastaut Syndrome
,
Jazz Pharma
,
Epidiolex
AbbVie bets $130M on UCB spinout, bagging early-phase Alzheimer's and depression prospect
Fierce Biotech
Tue, 03/1/22 - 10:42 am
Tags:
AbbVie
,
M&A
,
Neuroscience
,
Syndesi Therapeutics
,
UCB Pharma
,
Alzheimer's disease
,
depression
Watch out, AstraZeneca: UCB uncorks late-stage success for $2.1B Soliris rival
Endpoints
Fri, 02/4/22 - 11:11 am
Tags:
UCB Pharma
,
clinical trials
,
myasthenia gravis
,
AstraZeneca
,
Soliris
,
zilucoplan
Controversial opioid Zohydro ER pulled from the market
Endpoints
Thu, 02/3/22 - 12:00 am
Tags:
UCB Pharma
,
epilepsy
,
Zogenix
,
Zohydro ER
UCB to buy Zogenix for nearly $2B in 'first step' for M&A in 2022
BioPharma Dive
Wed, 01/19/22 - 11:12 am
Tags:
UCB Pharma
,
Zogenix
,
Fintepla
,
Dravet syndrome
Pages
1
2
3
4
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.